What's New in CLL?

 

Yale Cancer Center
C

CLL: Genotype to Phenotype and Beyond

By Yale Cancer Center FEATURING Catherine Wu
By Yale Cancer Center FEATURING Catherine Wu
177 views
February 12, 2024
0 Comments
Login to view comments. Click here to Login
What's New in CLL?
18:50
MyCancerHaven

CLL and MCL: Experts Discuss the Use of Pirtobrutinib

Feat. R. Vij, G. Shouse
20:58
Andrew Lipsky

CLL: Recent Updates on the Use of BTK Inhibitors

44:20
Yale Cancer Center

CLL: Genotype to Phenotype and Beyond

Feat. C. Wu
21:03
Scripps MD Anderson Cancer Center Clinical Hematology & Oncology 2024

Updates in CLL: Treatment for BTKi-Refractory and BTKi/BCL-2i-Refrac…

Feat. S. O'Brien
09:27
RWJBarnabas Health Rutgers Cancer Institute of New Jersey

CLL: Fixed Duration Treatment

Feat. J. Kra
08:26
Insights from 2023 ASH Annual Meeting

CLL/SLL Treatment With Post-cBTKi Pirtobrutinib: 30 Months Follow-Up…

Feat. J. Woyach
10:19
Alvaro Alencar

Pirtobrutinib in R/R CLL

05:12
Insights from 2023 ASH Annual Meeting

R/R CLL Treated With Fixed-Duration Pirtobrutinib Combined With Vene…

Feat. N. Shah
10:22
SOHO 2023 Eleventh Annual Meeting

CLL: Next Questions

Feat. N. Jain
08:45
Insights from 2023 ASH Annual Meeting

The Best of CLL: Highlights & Key Takeaways

Feat. V. Yazbeck